Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
With
Biogen Netherlands B.V
Novartis Europharm Limited
Merck Europe B.V.
Age
12–64
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women with a diagnosis of MS disease, regardless of MS clinical type, recorded at least once during the full study period.
Women with at least one recorded pregnancy after the MS diagnosis (including pregnancies ending in live birth, stillbirth, spontaneous abortion, ectopic pregnancy, or elective termination)
You may not be if
\- None.
Clareo Health | An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
